Investors Watch List : Merck & Co (NYSE:MRK), Activision Blizzard (NASDAQ:ATVI), Brooks Automation (NASDAQ:BRKS), Entergy Corporation (NYSE:ETR), CytRx Corporation (NASDAQ:CYTR)

Merck & Co. Inc. (NYSE:MRK) has been sued by Bristol-Myers Squibb Co (BMY) and Ono Pharmaceutical Co., Ltd. (Japan) (OPHLY) for patent infringement of Bristol-Myers’ novel PD-1 inhibitor, Optivo. Merck recently won the US Food and Drug Administration’s (FDA) approval for its own PD-1 drug, Keytruda. This made the company the first one to enter the US immunotherapy market, which is expected to reach $35 billion over the next decade. Merck & Co. Inc. (NYSE:MRK) belongs to Healthcare sector. Its net profit margin is 12.90% and weekly performance is 0.46%. On last trading day company shares ended up $60.76. Merck & Co. Inc. (NYSE:MRK) distance from 50-day simple moving average (SMA50) is 3.88%.

Activision Blizzard, Inc. (NASDAQ:ATVI) said Wednesday that this week’s release of its first-person shooter videogame “Destiny” was the biggest franchise videogame launch yet, signaling the company expects its big bet on the game to pay off. Activision Blizzard, Inc. (NASDAQ:ATVI) shares moved up 0.34% in last trading session and ended the day at $23.81. ATVI Gross Margin is 65.70% and its return on assets is 5.00%. Activision Blizzard, Inc. (NASDAQ:ATVI) quarterly performance is 10.85%.

Brooks Automation (NASDAQ:BRKS) SVP William T. Montone sold 3,000 shares of the stock in a transaction dated Tuesday, September 9th. The stock was sold at an average price of $11.08, for a total transaction of $33,240.00. Following the completion of the sale, the senior vice president now directly owns 192,622 shares of the company’s stock, valued at approximately $2,134,252. On 10 September, Brooks Automation, Inc. (NASDAQ:BRKS) shares moved up 0.72% and was closed at $11.12. BRKS EPS growth in last 5 year was 61.80%. Brooks Automation, Inc. (NASDAQ:BRKS) year to date (YTD) performance is 8.70%.

Entergy Corporation (NYSE:ETR) has received a “BBB” credit rating from Morningstar. The credit rating agency’s “BBB” rating indicates that the company is a moderate default risk. They also issued a neutral credit outlook for the company and gave their stock a three star rating. Entergy Corporation (NYSE:ETR) ended the last trading day at $76.16. Company weekly volatility is calculated as 1.39%and price to cash ratio as 21.04. Entergy Corporation (NYSE:ETR) showed a weekly performance of -1.27%.

CytRx Corporation (NASDAQ:CYTR), a biopharmaceutical research and development company specializing in oncology, today announced a change in the Company’s presentation time at the at Aegis 2014 Healthcare & Technology Conference. President and CEO Steven A. Kriegsman and Vice President of Business Development David Haen will present on Friday, September 12th at 10:45am Pacific Time. CytRx Corporation (NASDAQ:CYTR) shares moved up 0.59% in last trading session and ended the day on $3.39. CYTR return on assets is -67.30%. CytRx Corporation (NASDAQ:CYTR) quarterly performance is -32.47%.

Signup for free to be the first to receive exclusive free links. Now in your mailbox!
Join over 15,000 subscribers
Send me links

Your information will not be shared to anyone